Furthermore, PLIN5 was also significantly correlated with the OS of patients with GC, and when compared with the wild-type reference, mutated PLIN5 was a good prognostic factor for patients with GC (HR = 0.175, 95%CI: 0.043–0.715, p = 0.0152) (Figure 1D). This evidence concerns the gene PLIN5 and gastric cancer.